Camelid antibodies are single-variable, heavy chain-only antibodies (HcAb) that are naturally produced by camelids and sharks. Unlike conventional antibodies, camelid antibodies do not have a ...

Antibody engineering holds the potential for creating antibodies with multiple specificities, greater affinity for their targets, and fewer side effects. Among these approaches, more-or-less ...

Moderna's appetite for antibody tech spurs $6M bet on Nona's heavy chain only platform By Nick Paul Taylor Nov 11, 2022 7:30am Moderna Harbour BioMed antibody messenger RNA ...

BOSTON, July 17, 2024 /PRNewswire/ -- Immunocan announced the successful construction of new strain of fully human antibody platform: ImmuMab® HKL mouse. This new mouse was created by in-situ ...

Osaka University and Otsuka Pharmaceutical Co., Ltd. entered into an exclusive, worldwide license agreement for Otsuka to use R8H283, a novel antibody that recognizes the CD98 heavy chain ...

Researchers from Kexing Biopharm Co. Ltd. have published details on the development and preclinical characterization of GB18-06, a novel nanobody, also known as variable domain of heavy-chain antibody ...

More information: Bo Shi et al, Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs, Scientific Reports (2023). DOI: 10.1038/s41598-023-49450-1.